Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | PDCD1 | Q15116 | 15/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 15/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6338021 | 0.98 | EPHX2 (0.41) | EPHX2NR1H4PDCD1CD274CNR1 | |
| SCHEMBL6272499 | 0.88 | CD274 (0.39) | EPHX2NR1H4PDCD1CD274CNR1 | |
| Hydrochloric Acid SCHEMBL7097957 | 0.87 | CD274 (0.38) | EPHX2NR1H4PDCD1CD274CNR1 | |
| Hydrochloric Acid SCHEMBL6270873 | 0.82 | CD274 (0.36) | EPHX2NR1H4PDCD1CD274CNR1 | |
| SCHEMBL6338288 | 0.77 | MAPK1 (0.38) | EPHX2NR1H4CD274 | |
| Hydrochloric Acid SCHEMBL6339523 | 0.76 | ALDH1A1 (0.41) | EPHX2NR1H4 | |
| SCHEMBL6339754 | 0.75 | CXCR4 (0.42) | EPHX2NR1H4 | |
| SCHEMBL6340679 | 0.74 | HTT (0.55) | PDCD1CD274GAA | |
| Hydrochloric Acid SCHEMBL6336207 | 0.74 | CXCR4 (0.41) | EPHX2NR1H4GAA | |
| SCHEMBL4625409 | 0.73 | MTNR1B (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6936077-B2 | 1,3-diamino-4-(aminomethyl)—benzene derivatives and colorants containing the said compounds | WELLA AG (DE) | 2005-08-30 | — | — | US | disclosed |
| EP-1370514-A1 | 1,3-DIAMINO-4-(AMINOMETHYL)-BENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS | Wella Aktiengesellschaft (DE) | 2003-12-17 | — | — | EP | disclosed |
| US-20030172471-A1 | 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2003-09-18 | — | — | US | disclosed |
| WO-2002076923-A1 | 1,3-DIAMINO-4-(AMINOMETHYL)-BENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030172471-A1 | 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds | AOC1, DPYD, NDUFB4 | EPHX2 3250/4885NR1H4 3768/4885PDCD1 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.